News Category
Regentis Biomaterials' receipt of a Japanese Notice of Allowance for its GelrinC manufacturing process strengthens its IP portfolio and supports upcom...
VERAXA Biotech's collaboration with Ardigen uses AI to optimize its BiTAC platform, potentially improving target validation and reducing development r...
VERAXA Biotech's collaboration with Ardigen aims to use AI to identify optimal dual-target combinations, potentially reviving abandoned therapies and ...
Nanox Imaging's subsidiary signs exclusive UK reseller agreement with Vertec Scientific for its AI-powered HealthOST bone solution, following NICE rec...
Helix BioPharma's appointment of Dr. Markus Loeffler as CMO is a strategic move to accelerate its oncology pipeline, including the upcoming Phase Ib/I...
Quantum BioPharma reports significant cost reductions and FDA approval for its Phase 2 trial of Lucid-MS, a potential treatment for progressive multip...
Regentis Biomaterials is simultaneously advancing its GelrinC cartilage repair implant through US Phase III trials and European commercial rollout, ai...
Helix BioPharma reshuffles its board, appointing CEO Thomas Mehrling as director following Janusz Grabski's resignation, to better align governance wi...
Onco-Innovations is progressing its precision oncology candidate ONC010 through IND-enabling activities, positioning itself in the expanding field of ...
Researchers at the University of Manchester discovered that a small group of immune cells, often overlooked, are crucial for mobilizing and sustaining...
Quantum BioPharma reported reduced Q2 expenses and FDA approval to proceed with a Phase 2 trial for Lucid-MS, a potential treatment for progressive mu...
Regentis Biomaterials is simultaneously advancing its cartilage repair product GelrinC through US clinical trials and European commercialization, with...
HeartBeam's second-quarter results show progress in its heart attack detection studies and commercial launch, with cash runway extended into 2027.
Lantern Pharma's Q2 2026 results highlight progress in its AI-driven oncology pipeline, including promising LP-300 trial data and the establishment of...
NeOnc Technologies reported positive Phase 2a data for NEO100 in recurrent brain cancer, with significant survival benefits and regulatory clarity, po...
Quantum BioPharma's Lucid-MS focuses on inhibiting myelin degradation to address progression independent of relapse activity, a key driver of long-ter...
GeoVax announces its preparedness to contribute its MVA-based hemorrhagic fever vaccine expertise and candidates to the global response against the ra...
Nutriband CEO Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit, highlighting the company's AVERSA abuse-deterrent technology and ...
Regentis Biomaterials strengthens its global position in cartilage repair with a new Japanese patent and an improved manufacturing process, advancing ...
Quantum BioPharma's multiple sclerosis candidate Lucid-MS has received FDA clearance to enter Phase 2 trials, marking a significant step toward a pote...
PX1 Research expands domestic manufacturing with cGMP quality control and HPLC purity verification, ensuring 99%+ purity on all research peptides, whi...
NanoViricides received approval to conduct a Phase II trial of its oral antiviral NV-387 against the ongoing Ebola outbreak in the DRC, potentially of...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in prostate and triple-negative breast can...
Quantum BioPharma's FDA approval to advance Lucid-MS into Phase 2 trials marks a pivotal step for a novel neuroprotective approach that could differen...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, propelled by TONMYA's market uptake, signaling a successful commercial launch for the ...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, driven by TONMYA sales, marking significant commercial progress for the newly approved...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through clinical trials and regulatory pathways, positioning it to ...
Quantum BioPharma is progressing its investigational MS therapy Lucid-MS and its supplement unbuzzd, addressing both myelin repair and alcohol metabol...
Quantum BioPharma is developing a two-pronged approach to neurological health, targeting myelin repair in multiple sclerosis and alcohol metabolism, w...
VERAXA Biotech's proprietary BiTAC platform positions it for potential partnerships and licensing deals in the high-value ADC and T-cell engager marke...
A case in Spain where a patient's neurocysticercosis mimicked brain cancer highlights the diagnostic challenges and the urgent need for better treatme...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its patent portfolio, undersco...
A new liquid biopsy offers a simple way to forecast which advanced lung cancer patients will benefit from immunotherapy, potentially aiding drug devel...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA vaccine, positioning it for a pivotal P...
Onco-Innovations' integrated approach to cancer drug development, leveraging PNKP-targeted DDR inhibition, nanoparticle delivery, and AI, represents a...
Nagoya University researchers discovered that the immune protein C3, when produced by tumor cells, may boost the effectiveness of immunotherapy, offer...
VolitionRx's new Capture-Seq technology isolates over 99% pure circulating tumor DNA, potentially enabling earlier cancer detection and monitoring, wi...
Tonix Pharmaceuticals' participation in key investor conferences underscores its commitment to advancing innovative treatments for fibromyalgia and ot...
VERAXA Biotech's VXA-222 bispecific ADC program moves past discovery, and the company strengthens its IP estate with new patent filings, underpinning ...
NeuroThera Labs has initiated a Phase IIb clinical trial at Yale Child Study Center for SCI-110, a first-of-its-kind cannabinoid-based treatment for T...
SRX Global's acquisition of a stake in Vistagen Therapeutics highlights its strategy of investing in undervalued high-conviction companies, potentiall...
SRX Global's acquisition of a stake in Vistagen Therapeutics signals a strategic move to unlock shareholder value in a promising neuroscience biopharm...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital shows promising early signals, potentially improving measurement of mye...
Biotech Labz Supply Inc has expanded its online catalog to include 11 documented research peptides, enhancing procurement options for qualified resear...
Oncotelic Therapeutics will showcase its advancements in intravenous Everolimus trials, Deciparticle platform validation, and AI-driven drug discovery...
Tonix Pharmaceuticals announced FDA feedback supporting its adaptive Phase 2 study of TNX-4800, a long-acting monoclonal antibody for Lyme disease pre...
GeoVax underscores recent independent research suggesting cross-reactive immune responses to ebolaviruses, reinforcing the strategic value of its MVA-...
Regentis Biomaterials is advancing its GelrinC platform, which could address a significant unmet need in cartilage repair by offering a minimally inva...
